ARCHIVES

More Cost-Effective To Use Cetuximab In Patients With Wild-Type KRAS Gene

This article is from The Cancer Letter archive.

Vol. 32 No. 8 | August 28, 2009

Download PDF Visit The Full Archive

Related Articles

Decline In Breast Cancer May Be Related to Drop In HT

March 25, 2011

In Brief: san Antonio’s ICRC Gets a New Name, SACI; Blum Is deputy Oncology Director At Kaplan

May 14, 1993

DCPC Advisors Okay Omnibus Prevention Program Announcement

January 24, 1992

In Brief: New Presidents Take Office At ONS, ONCC, ARS; Baird Wins Awards; New VP In Houston

July 8, 1994

In Brief: Morgan Named Director Of UAMS Myeloma Institute

April 25, 2014

Clinical Trials Approved By NCI In November

December 28, 2001